ghk-cu injection vs topical How Often to Inject Injectable vs Topical GHK-CU: Which
Description
At 30 min after isoprenaline 75 mg/kg s.c., we noted an early multiorgan failure (brain, heart, lung, liver, kidney and gastrointestinal lesions), thrombosis, intracranial (superior sagittal sinus) hypertension, portal and caval hypertension, and aortal hypotension, full presentation (or attenuation by BPC 157 therapy (given at 5 min after isoprenaline) via activation of the azygos vein) (Figure 1, Figure 2, Figure 3, Figure 4, Figure 5, Figure 6, Figure 7, Figure 8 and Figure 9)
H., El-Kholy, M

Some practitioners report that lower, more frequent doses (75-100mcg nightly) produce better stress-related benefits than higher intermittent doses

[7] Research has indicated a potential area of interest for DSIP in the study of withdrawal symptoms from opiate and alcohol addictions, which has been supported by the results of studies in animals conducted by Tissot and the fact, that DSIP possesses an agonistic activity on opiate receptors
Phase One: Gastric and Appetite Effects (4872 Hours) The GLP-1 receptor agonist component
